Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.
Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...
On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...
Medical Xpress on MSN8d
New findings could make off-the-shelf CAR T cell therapy a realityCAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...
Researchers at Cellectis leveraged gene editing to create a CAR T cell that acts in an IF/THEN system. Traditional methods to develop CAR T cells that use the patient’s cells introduce challenges ...
The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...
Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...
Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
Preliminary findings from the phase 1 trial showed that GCC19CART, a novel CAR T-cell therapy, demonstrated clinical ...
Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...
A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback